Pfizer, Inc. Irish subsidiary penalized for antiboycott violations

Posted 5/14/08

The Bureau of Export Administration (BXA) penalized Howmedica International, Inc., a subsidiary of the New York based medical products manufacturer Pfizer Inc., $30,000 for violating the antiboycott …

This item is available in full to subscribers.

Please log in to continue

Log in